Gemcitabine for advanced endometrial cancer: A retrospective study of the memorial sloan-kettering cancer center experience Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma, Clear Cell
  • Antimetabolites, Antineoplastic
  • Cystadenocarcinoma, Serous
  • Deoxycytidine
  • Endometrial Neoplasms
  • Neoplasm Recurrence, Local

abstract

  • In a mixed population of patients with previously treated advanced endometrial cancer, gemcitabine was well tolerated and showed modest activity. Patients with clear cell histology appeared to have greater likelihood of benefit.

publication date

  • June 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3904291

Digital Object Identifier (DOI)

  • 10.1097/IGC.0b013e31824a33a2

PubMed ID

  • 22635030

Additional Document Info

start page

  • 807

end page

  • 11

volume

  • 22

number

  • 5